| Literature DB >> 25889647 |
Dongfang Gao1, Shengjun Wang2, Haoran Li3, Huili Yu4, Qingsheng Qi5.
Abstract
BACKGROUND: The Gram-negative bacterium Escherichia coli has been widely used as a cell factory for the production of proteins and specialty chemicals because it is the best characterized host with many available expression and regulation systems. However, recombinant proteins produced in Escherichia coli are generally intracellular and often found in the form of inclusion bodies. Extracellular production of proteins is advantageous compared with intracellular production because extracellular proteins can be purified more easily and can avoid protease attack, which results in higher product quality. In this study, we found a catalytic domain of a cellulase (Cel-CD) and its N-terminus can be employed as carriers for extracellular production of recombinant proteins.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25889647 PMCID: PMC4399388 DOI: 10.1186/s12934-015-0230-8
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Secretion analysis of Cel-CD in BL21 (DE3). SDS-PAGE analysis and activity assay of the Cel-CD in the culture medium. Samples were collected by centrifugation at the indicated times after induction. The endoglucanase activity of the secreted Cel-CD was determined by Congo red staining as described in the Materials and Methods. Molecular size markers are shown in kDa. Lane M is the marker; Lane C is the control of collected cells.
Figure 2Subcellular localization and accumulation process analysis of Cel-CD. (A) Subcellular localization of Cel-CD. Cells were harvested 4 and 16 h after induction and washed with 1 mL of 100 mM MOPS (pH 7.0), then subjected to cold osmotic shock to separate the periplasm from spheroplasts. (B) The accumulation process of Cel-CD at different locations. Cells were harvested after 8 h induction and washed with 1 mL of 100 mM MOPS (pH 7.0), then suspended in 50 mL of fresh LB containing 80 μg/mL chloramphenicol. The quantification of Cel-CD was performed by Bio-Rad Quantity One Version 4.2.1. Lanes are marked as: S, spheroplasts; P, periplasm; H, hypertonic solution; M, medium.
Figure 3Cell lysis determination and inactive Cel-CD secretion analysis. (A) Immunoblotting detection of Cel-CD, GroEL and MBP in the culture medium. Samples were subjected to immunoblotting with an anti-Cel-CD antibody, an anti-GroEL antibody or an anti-MBP antibody. (B) SDS analysis of cellulase (wt) and its mutants (E160Q, E160Q&E274Q) secreted into the culture medium. The activities of the secreted mutants of Cel-CD (E160Q, E160Q&E274Q) were analyzed by Congo red staining method (4 h, 6 h, 8 h, 16 h). (C) TEM images of E. coli BL21 (DE3) that containing different plasmids. (1) pET28a/cel, (2) pET28a/E160Q, (3) pET28a/E160Q&E274Q, (4) pET28a. Protein samples were separated on 12% SDS-PAGE. Aliquots corresponding to 20 μL of the culture medium were loaded onto the gel. Molecular size markers are shown in kDa. Lane M is the marker; Lane C is the control of collected cells.
Figure 4The expression and secretion of Cel-CD and its N-terminal nested-deletion mutants. Cells were harvested 16 h after induction and washed with 1 mL of 100 mM MOPS (pH 7.0). The whole cells (1), the supernatant of the disrupted cells (2) and the released protein in the medium (3) were separated on 12% SDS-PAGE.
Figure 5Secretion analysis of the fusion proteins using Cel-CD/N20 as a partner. (A) Fusion of target proteins with Cel-CD. Samples were collected after 24 h induction and separated on 12% SDS-PAGE. (B) Fusion of the target proteins with the N-terminal 20 residues of Cel-CD (N20). Samples were collected after 24 h induction and separated on 15% SDS-PAGE. (C) Quantitative comparison of extracellular proteins using different fusions. The dark gray column represents the Cel-CD fusion, whereas the light grey column represents the N20 fusion. Aliquots corresponding to 20 μL of the culture medium were loaded onto the gel. Molecular size markers are shown in kDa. The quantification of Cel-CD was performed by Bio-Rad Quantity One Version 4.2.1.
The strains and plasmids used in this study
|
|
| |
|---|---|---|
|
| ||
|
| F−
| Invitrogen |
|
|
| Novagen |
|
| ||
| pET28a | 5.4 kb, f1 ori, T7 promoter, KanR | Novagen |
| pCel | pET28a, | This study |
| pN20 | pET28a, 60 bp at 5′ region of | This study |
| pΔ5cel | pET28a, | This study |
| pΔ10cel | pET28a, | This study |
| pΔ15cel | pET28a, | This study |
| pΔ20cel | pET28a, | This study |
| pΔ30cel | pET28a, | This study |
| pCelNRN1 | pET28a, | This study |
| pCelMBP | pET28a, | This study |
| pCelCBD | pET28a, | This study |
| pCelGlpQ | pET28a, | This study |
| pCelPelC | pET28a, | This study |
| p20NRN1 | pET28a, | This study |
| p20MBP | pET28a, | This study |
| p20CBD | pET28a, | This study |
| p20GlpQ | pET28a, | This study |
| p20PelC | pET28a, | This study |
| E170Q | pET28a, the mutated | This study |
| E170Q&E275Q | pET28a, the mutated | This study |
The primers used in this study
|
|
|
| Cel-CD- | 5′-TTTT |
| Cel-CD- | 5′-TTTT |
| Cel-CD- | 5′-TTTT |
| Cel-20- | 5′-TTTT |
| Cel-CD5- | 5′-TTTT |
| Cel-CD10- | 5′-TTTT |
| Cel-CD15- | 5′-TTTT |
| Cel-CD20- | 5′-TTTT |
| Cel-CD30- | 5′-TTTT |
| NRN1- | 5′-TTTT |
| NRN1- | 5′-TTTT |
| MBP- | 5′-TTTT |
| MBP- | 5′-TTTT |
| GlpQ– | 5′-TTTT |
| GlpQ- | 5′-TTTT |
| CBD– | 5′-TTTT |
| CBD- | 5′-TTTT |
| pelC– | 5′-TTTT |
| pelC- | 5′-TTTT |
| Glu160Gln-Forward | 5′-TTATTTATGAGTTAGCGAAT |
| Glu160Gln-Reverse | 5′- GATTCGCTAACTCATAAATAATGTGTGGATTGT-3′ |
| Glu274Gln-Forward | 5′-GAGTAGCGGTATTTGCGACA |
| Glu274Gln-Reverse | 5′-GTGTCGCAAATACCGCTACTCCGTTTTCTAACG-3′ |